Patent Assignment
Reel/Frame 067245/0492
Assignment of Assignor's Interest
Recorded: 2024-04-27
Pages: 37
Assignor
ENDO USA, INC.
Executed: 2024-04-24
Assignee
ENDO OPERATIONS LIMITED
FIRST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD, BALLSBRIDGE, 4, IRELAND
Covered Properties
(119)
Pelvic Disorder Treatment Device
Sustained Release Formulations of Metformin
Surgical Article and Methods for Treating Female Urinary Incontinence
Handle and Surgical Article
Non-Surgical Incontinence Treatment System and Method
Electrically Heated/Phase Change Probe Temperature Control
Heating Method for Tissue Contraction
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Patent:
7,229,636 →
Application:
10/787,385 →
Incontinence Treatment with Urethral Guide
Prolapse Repair
Nasal Calcitonin Formulations Containing Chlorobutanol
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Patent:
7,404,489 →
Application:
10/814,399 →
Method and Apparatus for Treating Pelvic Organ Prolapse
Method and Apparatus for Cystocele Repair
Delayed Release Dosage Forms
Endo-Pelvic Fascia Penetrating Heating Systems and Methods for Incontinence Treatment
Transobturator Surgical Articles and Methods
Heating Method for Tissue Contraction
Surgical Implants and Related Methods
Compositions and Methods for Treating Precocious Puberty
Method for Supporting Vaginal Cuff
Transobturator Surgical Articles and Methods
Controlled Release Formulations of Octreotide
Apparatus for Treating Stress and Urge Incontinence
Oxymorphone Controlled Release Formulations
Sustained release formulations of nalbuphine
Method of Inserting an Object Under the Skin
Oxymorphone Controlled Release Formulations
Pelvic Floor Implant System and Method of Assembly
Methods and Systems for Treatment of Prolapse
Prolapse Repair
Method and Apparatus for Cystocele Repair
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Multi-Leveled Transgluteal Tension-Free Levatorplasty for Treatment of Rectocele
Implant Device Release Agents and Methods of Using Same
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Sustained Release Formulations of Nalbuphine
Delivery of Dry Formulations of Octreotide
Controlled Release Formulations of Octreotide
Electrode Sling for Treating Stress and Urge Incontinence
Method and Apparatus for Treating Pelvic Organ Prolapse
Combination Treatment for Bladder Cancer
Method and Apparatus for Prolapse Repair
An Implantable Device for the Sustained Release of a Polypeptide
Octreotide Implant Having a Release Agent and Uses Thereof
Kit For Levator Avulsion Repair
Vitamin B12 Nasal Spray and Method of Use
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
Controlled Release Formulations of Octreotide
A Method of Manufacturing an Implantable Device
Nasal Calcitonin Formulations Containing Chlorobutanol
Method for Supporting Vaginal Cuff
Octreotide Implant Having a Release Agent
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Prolapse Repair
Nasal Calcitonin Formulations Containing Chlorobutanol
Apparatus and Method for Repairing Vaginal Reconstruction
Sustained Release Formulation of Nalbuphine
Method of Manufacturing an Implantable Device
Methods and Systems for Treatment of Prolapse
Crystalline, Anhydrous Forms of Oxymorphone Hydrochloride
Method for Supporting Vaginal Cuff
Sustained Release Formulation of Nalbuphine
Prolapse Repair
Sustained Release Formulation of Nalbuphine
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
Cyanocobalamin Low Viscosity Aqueous Formulations for Intranasal Delivery
Crystalline, Anhydrous Forms of Oxymorphone Hydrochloride
Epinephrine Formulations
Patent:
9,119,876 →
Application:
14/657,990 →
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Patent:
9,375,478 →
Application:
14/717,882 →
Vitamin B12 Nasal Spray and Method of Use
Methods and Systems for Treatment of Prolapse
Epinephrine Formulations
Patent:
9,295,657 →
Application:
14/818,121 →
Epinephrine Formulations
Vitamin B12 Nasal Spray and Method of Use
Systems and Methods for Treating a Pelvic Disorder
Crystalline, Anhydrous Forms of Oxymorphone Hydrochloride
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Sustained Release Formulation of Nalbuphine
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
Sustained Release Formulations of Nalbuphine
Systems and Methods for Treating a Pelvic Disorder
Epinephrine Formulations
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Epinephrine Formulations
Pre-Filled Syringe Containing Sugammadex
Patent:
11,097,023 →
Application:
16/919,790 →
Peptide Congeners with Polymer Excipients
Application:
17/104,102 →
Publication:
US 2021/0077568
Implantable Device for the Delivery of Octreotide and Methods of Use Thereof
Application:
17/172,821 →
Publication:
US 2021/0161994
Vasopressin Formulations for Use in Treatment of Hypotension
Epinephrine Formulations
Epinephrine Formulations
Application:
17/694,165 →
Publication:
US 2023/0285326
Varenicline Compound and Process of Manufacture Thereof
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
Application:
17/838,636 →
Publication:
US 2022/0313688
Vasopressin Formulations for Use in Treatment of Hypotension
Application:
17/861,353 →
Publication:
US 2023/0256048
Varenicline Compound and Process of Manufacture Thereof
Patent:
11,717,524 →
Application:
17/930,824 →
Varenicline Compound and Process of Manufacture Thereof
Application:
17/930,940 →
Publication:
US 2023/0285404
Vareniciline Compound and Process of Manufacture Thereof
Controlled Release Formulations of Octreotide
Application:
18/230,990 →
Delivery of Dry Formulations of Octreotide
Application:
18/237,644 →
Varenicline Compound and Process of Manufacture Thereof
Compositions and Methods for Treating Precocious Puberty
Application:
18/419,099 →
Controlled Release Formulations of Octreotide
Application:
18/422,859 →
Delivery of Dry Formulations of Octreotide
Application:
18/428,462 →
Epinephrine Formulations
Application:
18/470,256 →
Publication:
US 2024/0091176
Epinephrine Formulations
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 4, 2004
From: MELLIER, GEORGES
To: AMS RESEARCH CORPORATION
Reel/Frame 015850/0848 →
Security Agreement
Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →
Release of Patent Security Interest
Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: PENWEST PHARMACEUTICALS CO.
Reel/Frame 032380/0963 →
Release of Patent Security Interest
Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
Release of Patent Security Interest
Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMERICAN MEDICAL SYSTEMS, INC.
Reel/Frame 032379/0501 →
Grant of Security Interest in Patents
Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
Release of Security Interest
Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
Confirmatory Grant of Security Interest in United States Patents
Sep 25, 2015
From: PAR PHARMACEUTICAL, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 036687/0821 →
Release of Security Interest
Sep 30, 2015
From: BANK OF AMERICA, N.A.
To: PAR PHARMACEUTICAL, INC.; INNOTEQ, INC.; PAR PHARMACEUTICAL COMPANIES, INC.
Reel/Frame 036695/0782 →
Change of Name
Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0199 →
Change of Name
Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0607 →
Change of Name
Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0728 →
Change of Name
Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0318 →
Change of Name
Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0354 →
Assignment of Assignor's Interest
Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0260 →
Assignment of Assignor's Interest
Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0425 →
Change of Name
Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0535 →
Assignment of Assignor's Interest
Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0745 →
Change of Name
Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0919 →
Corrective Assignment to Correct the Conveying Party Name Previously Recorded at Reel: 037300 Frame: 0607. Assignor(S) Hereby Confirms the Assignment.
Jan 11, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037514/0402 →
Change of Name
Jan 18, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037551/0749 →
Assignment of Assignor's Interest
Jan 18, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037551/0626 →
Assignment of Assignor's Interest
Feb 24, 2016
From: AMERICAN MEDICAL SYSTEMS, LLC
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 037901/0883 →
Assignment of Assignor's Interest
Feb 24, 2016
From: AMS RESEARCH, LLC
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 037901/0941 →
Corrective Assignment to Correct the Conveying Party Data; Previously Recorded on Reel 037300 Frame 0199. Assignor(S) Hereby Confirms the Change of Name.
Feb 25, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037916/0028 →